AbbVie is a global leader in developing, testing, and commercializing innovative pharmaceuticals. The Chicago-based healthcare giant has a large presence in over 170 countries worldwide.
AbbVie is a research-driven company that invests over 6 billion annually in developing new treatments for the same conditions. Its research teams are dedicated to creating patient-focused solutions that make a difference in people's lives.
AbbVie produces over 40 world-class pharmaceuticals, providing life-improving treatments to over 4 million patients annually.
AbbVie has innovative joint ventures worldwide, ranging from generics and biological medicines to medical devices and diagnostics.
As part of its commitment to corporate citizenship, AbbVie actively supports charitable organizations that improve access to care in vulnerable communities.
AbbVie is a publicly traded company with a total market value of over 115 billion dollars.
AbbVie is committed to sustainable business practices, holding itself to the highest environmental, economic, and societal standards.
AbbVie partners with leading experts in academic, governmental, and industry-related entities to support and advance healthcare innovation in areas of unmet medical needs.
AbbVie incorporates digital technologies and data science into almost every aspect of its business, from product design and patient-experience management to data analytics and real-world research.
AbbVie invests in strategic partnerships with leading organizations - such as hospitals, universities, insurers, diagnostic providers, and other healthcare companies - to drive better healthcare solutions worldwide.
AbbVie's state-of-the-art research centers offer support and resources to patients in areas such as personalized medicine, clinical trials, and medical assistance programs.